Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Clomiphene-resistant PCOS ovulation induction: clomiphene plus tamoxifen versus clomiphene plus gonadotropin
IRCT138904121760N8Phase 2Completed
- Sponsor
- Babol University of Medical Sciences
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label trial of clomiphene and tamoxifen in polycystic ovary syndrome (PCOS) (2 arms), sponsored by Babol University of Medical Sciences. Started Sep 2010; status: completed.
02
Drugs
clomiphenetamoxifen
03
Conditions
polycystic ovary syndrome (PCOS)
Beyond the preview
Go deeper on IRCT138904121760N8.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT138904121760N8.